Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
10.1002/edm2.105
Saved in:
Main Authors: | Noureddin, M., Muthiah, M.D., Sanyal, A.J. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
Blackwell Publishing Ltd
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198649 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
HUMAN IPSC-DERIVED KUPFFER CELL-BASED MODEL FOR IMMUNE MEDIATED TOXICITY AND NONALCOHOLIC STEATOHEPATITIS
by: HUANG, XIAOZHONG
Published: (2021) -
Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
by: Chua, Damien, et al.
Published: (2023) -
Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
by: Hu, Y.-B., et al.
Published: (2021) -
Myeloperoxidase-Sensitive T1 and T2 Switchable MR Imaging for Diagnosis of Nonalcoholic Steatohepatitis
by: Liu, Jingjing, et al.
Published: (2023) -
A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)
by: Lee, Y.-M., et al.
Published: (2016)